300463.SZ
300463.SZ
CNE1000020H3
MAKER BIOTECHNOLOGY
Loading chart...

Company Profile

Maccura Biotechnology Co.Ltd engages in the research, development, manufacture, and sale of in vitro diagnostic products; and provides related services for medical laboratories in China and internationally. The company offers laboratory automation solutions, such as hematology analysis workstations; immunoassay products, such as chemiluminescence analyzers and reagents; molecular products, such as digital PCR and extraction systems, and PCR kits; urinalysis analyzer systems and semi-automatic urine analyzers; and hemostasis solutions, including coagulation and semi-automatic coagulation analyzers. It also provides clinical chemistry products, such as glycohemoglobin and protein analyzer, biochemistry systems, and chemistry regents; blood group product solutions; and pathology solutions, such as a liquid-based cytology processing system technologies. In addition, the company offers Mike Smart Lab, a patient-centered medical laboratory system solution based on automation and digital intelligence. Maccura Biotechnology Co.Ltd was founded in 1994 and is headquartered in Chengdu, China.

Related stocks

300406.SZ
300406.SZ • China
BSBE
12.14 CNY
1.06B USD 1Y -9.7%
300685.SZ
300685.SZ • China
AMOYDX
20.3 CNY
1.18B USD 1Y -11.6%
603108.SS
603108.SS • China
SHANGHAI RUNDA MEDICAL TECHNOLO
9.97 CNY
901.98M USD 1Y -36.5%
4694.T
4694.T • Japan
BML INC
3,650 JPY
864.57M USD 1Y +1.2%
603882.SS
603882.SS • China
GUANGZHOU KINGMED DIAGNOSTICS G
28.82 CNY
2B USD 1Y -3.4%
METROPOLIS.NS
METROPOLIS.NS • India
METROPOLIS HEALTHCARE LTD
529.25 INR
1.13B USD 1Y +4.2%
THYROCARE.BO
THYROCARE.BO • India
Thyrocare Technologies Limited
499 INR
820.66M USD 1Y +22%
4544.T
4544.T • Japan
H.U. GROUP HLDGS INC
3,580 JPY
1.23B USD 1Y -4%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
37.3% p.a.
Max Drawdown (5Y)
-76.9%
Sharpe Ratio (5Y)
-0.60
Beta Factor
0.21
Size Class
Mid Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
Unprofitable business model: The company is currently generating net losses.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (37.3% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -87.2% in the extended horizon.
ende